Skip to main content

What the FDA labels say about taking them together

Darunavir and ticagrelor

Darunavir's FDA label of August 29, 2025 names ticagrelor in its drug interactions section; the ticagrelor label PlainMeds reads does not name darunavir. The darunavir label: “Co-administration of PREZISTA/ritonavir and ticagrelor is not recommended.”

Check it at the source: the darunavir FDA label on DailyMed (effective August 29, 2025, Janssen Products LP); the ticagrelor FDA label on DailyMed (effective May 7, 2026, AstraZeneca Pharmaceuticals LP).

What does the darunavir label say about ticagrelor?

Darunavir label, drug interactions

Concomitant Drug Class Drug Name Examples: Platelet aggregation inhibitor: ticagrelor; Effect on Concentration of Darunavir Or Concomitant Drug: ↑ ticagrelor; Clinical Comment: Co-administration of PREZISTA/ritonavir and ticagrelor is not recommended.

Source: FDA drug label (PREZISTA), Janssen Products LP, effective August 29, 2025 (SPL set 814301f9-c990-46a5-b481-2879a521a16f), via openFDA; the full label on DailyMed

What does the ticagrelor label say about darunavir?

Ticagrelor's label (effective May 7, 2026) does not name darunavir in these sections. A label lists what its studies and reports found; it is not a complete list.

Source: FDA drug label (BRILINTA), AstraZeneca Pharmaceuticals LP, effective May 7, 2026 (SPL set f7b3f443-e83d-4bf2-0e96-023448fed9a8), via openFDA; the full label on DailyMed

These are the labels' own sentences. PlainMeds does not grade interactions; a pharmacist or prescriber can say what they mean for one person's medicines.

Both medicines on the record

13Darunavir generic labelers
28Ticagrelor generic labelers
DarunavirTicagrelor
Labeled forHIVHeart attack and coronary artery disease, Stroke prevention
Boxed warningNoYes
Pharmacy cost (NADAC)$1.16 per tablet 600 mg tablet$0.253 per tablet 90 mg tablet
Shortage nowNo current entryNo current entry

Source: FDA NDC Directory, CMS NADAC of October 7, 2026 and the FDA Drug Shortage Database (FDA files October 8, 2026)

What next?